Jeffrey Lancet Selected Research

Jeffrey Lancet Research Topics

Disease

14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2023 - 06/2009
10	Neoplasms (Cancer) 02/2024 - 08/2011
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 03/2011
4	Leukemia 01/2017 - 06/2010
3	Disease Progression 02/2024 - 07/2011
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2024 - 01/2016
2	Thrombocytopenia (Thrombopenia) 04/2023 - 12/2020
2	Hypersensitivity (Allergy) 01/2023 - 06/2013
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 06/2013
2	Acute Promyelocytic Leukemia 01/2021 - 01/2016
2	Splenomegaly 10/2014 - 06/2003
1	Leukopenia 04/2023
1	Febrile Neutropenia 04/2023
1	Neutropenia 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 12/2020
1	Anemia 12/2020
1	Cytopenia 01/2020
1	Leukocytosis (Pleocytosis) 10/2014
1	Chronic Disease (Chronic Diseases) 06/2013
1	Juvenile Myelomonocytic Leukemia 06/2013
1	Fatigue 04/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2013
1	Melanoma (Melanoma, Malignant) 08/2011
1	Hypoalbuminemia 03/2011
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 06/2010
1	Pneumonia (Pneumonitis) 01/2004
1	Multiple Myeloma 01/2004
1	Headache (Headaches) 01/2004
1	Fever (Fevers) 06/2003

Drug/Important Bio-Agent (IBA)

8	Lenalidomide (CC 5013)FDA Link 02/2024 - 07/2011
4	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 12/2012
2	2019-nCoV Vaccine mRNA-1273IBA 12/2023 - 01/2023
2	VaccinesIBA 12/2023 - 01/2023
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 06/2013
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2011
2	CPX-351IBA 10/2022 - 01/2020
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2020 - 01/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2018
2	Decitabine FDA Link 01/2018 - 03/2015
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	Methylprednisolone FDA LinkGeneric 02/2024
1	ofatumumab FDA Link 02/2024
1	COVID-19 VaccinesIBA 12/2023
1	Neutralizing AntibodiesIBA 12/2023
1	AntibodiesIBA 12/2023
1	eprenetapoptIBA 04/2023
1	mRNA VaccinesIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	magrolimabIBA 01/2023
1	proto-oncogene proteins pimIBA 01/2023
1	venetoclaxIBA 01/2021
1	ImidesIBA 12/2020
1	Janus Kinase InhibitorsIBA 12/2020
1	Thalidomide (Thalomid)FDA Link 12/2020
1	Immunomodulating AgentsIBA 12/2020
1	glasdegibIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2016
1	telomerase RNA (bTR)IBA 01/2016
1	HematinicsIBA 11/2015
1	pexmetinibIBA 03/2015
1	p38 Mitogen-Activated Protein KinasesIBA 03/2015
1	Phosphotransferases (Kinase)IBA 03/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	Histones (Histone)IBA 01/2015
1	Interleukin-3 (Interleukin 3)IBA 06/2013
1	CytokinesIBA 06/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2013
1	Imatinib Mesylate (Gleevec)FDA Link 04/2013
1	Tyrosine Kinase InhibitorsIBA 04/2013
1	Dasatinib (BMS 354825)FDA Link 04/2013
1	nilotinib FDA Link 04/2013
1	Indicators and Reagents (Reagents)IBA 08/2011
1	IsotopesIBA 08/2011
1	Peptides (Polypeptides)IBA 08/2011
1	ProteomeIBA 08/2011
1	Serum AlbuminIBA 03/2011
1	AntigensIBA 06/2010
1	Glutathione (Reduced Glutathione)IBA 06/2009
1	TabletsIBA 06/2009
1	ProdrugsIBA 06/2009
1	gamma-Glu-S-BzCys-PhGly diethyl ester (T.199)IBA 06/2009
1	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2004
1	Semaxinib (SU5416)IBA 01/2004
1	Uric Acid (Urate)IBA 06/2003

Therapy/Procedure

12	Therapeutics 02/2024 - 01/2004
5	Drug Therapy (Chemotherapy) 02/2024 - 07/2011
3	Cell Transplantation 02/2024 - 06/2014
2	Induction Chemotherapy 10/2022 - 01/2018
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Aftercare (After-Treatment) 01/2017
1	Hematopoietic Stem Cell Transplantation 03/2011